Detalles de la búsqueda
1.
Emicizumab is well tolerated and effective in people with congenital hemophilia A regardless of age, severity of disease, or inhibitor status: a scoping review.
Res Pract Thromb Haemost
; 8(4): 102415, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38812987
Resultados
1 -
1
de 1
1
Próxima >
>>